Winston-Salem, NC
Website: Novant Health Oncology Specialists
Linked In
You Tube
Novant Health Oncology Specialists
Trials at this location:
HCRN BRE18-334
A Phase II circulating tumor DNA enriched, genomically directed post-neoadjuvant trial for patients with residual triple negative breast cancer (PERSEVERE)
Status: Open to Accrual
Facebook
Hoosier Cancer Research Network on Facebook
Linked In
You Tube
Twitter